Cynata Therapeutics Limited (CYYNF)
USD 0.3
(117.39%)
USD 0.3
(117.39%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - AUD | -100.0% |
| 2023 | 1.65 Million AUD | -78.71% |
| 2022 | 7.77 Million AUD | 402.6% |
| 2021 | 1.54 Million AUD | -77.95% |
| 2020 | 7.01 Million AUD | 435.83% |
| 2019 | 1.3 Million AUD | -4.84% |
| 2018 | 1.37 Million AUD | -21.37% |
| 2017 | 1.74 Million AUD | 59.03% |
| 2016 | 1.09 Million AUD | 285.08% |
| 2015 | 285.58 Thousand AUD | 1039.69% |
| 2014 | 25.05 Thousand AUD | -26.22% |
| 2013 | 33.96 Thousand AUD | -79.09% |
| 2012 | 162.45 Thousand AUD | -27.13% |
| 2011 | 222.93 Thousand AUD | 95.77% |
| 2010 | 113.87 Thousand AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 350.56 Thousand AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q1 | 1.27 Million AUD | 1835.39% |
| 2024 Q2 | 1.27 Million AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2023 FY | 1.65 Million AUD | -78.71% |
| 2023 Q1 | 900.5 Thousand AUD | 125.25% |
| 2023 Q3 | -73.34 Thousand AUD | -108.15% |
| 2023 Q4 | -73.34 Thousand AUD | 0.0% |
| 2023 Q2 | 900.5 Thousand AUD | 0.0% |
| 2022 Q3 | 399.77 Thousand AUD | -88.53% |
| 2022 Q2 | 3.48 Million AUD | 0.0% |
| 2022 FY | 7.77 Million AUD | 402.6% |
| 2022 Q1 | 3.48 Million AUD | 359.05% |
| 2022 Q4 | 399.77 Thousand AUD | 0.0% |
| 2021 Q2 | 13.74 Thousand AUD | 0.0% |
| 2021 Q1 | 13.74 Thousand AUD | -98.93% |
| 2021 FY | 1.54 Million AUD | -77.95% |
| 2021 Q3 | 759.28 Thousand AUD | 5423.64% |
| 2021 Q4 | 759.28 Thousand AUD | 0.0% |
| 2020 Q4 | 1.28 Million AUD | 0.0% |
| 2020 Q1 | 2.22 Million AUD | 1779952.8% |
| 2020 FY | 7.01 Million AUD | 435.83% |
| 2020 Q2 | 2.22 Million AUD | 0.0% |
| 2020 Q3 | 1.28 Million AUD | -42.42% |
| 2019 Q1 | 654.4 Thousand AUD | 1796.66% |
| 2019 Q2 | 654.4 Thousand AUD | 0.0% |
| 2019 FY | 1.3 Million AUD | -4.84% |
| 2019 Q4 | -125.00 AUD | 0.0% |
| 2019 Q3 | -125.00 AUD | -100.02% |
| 2018 Q4 | -38.57 Thousand AUD | 0.0% |
| 2018 Q2 | 726.13 Thousand AUD | -0.0% |
| 2018 Q1 | 726.13 Thousand AUD | 5818.07% |
| 2018 FY | 1.37 Million AUD | -21.37% |
| 2018 Q3 | -38.57 Thousand AUD | -105.31% |
| 2017 Q4 | -12.69 Thousand AUD | 0.0% |
| 2017 FY | 1.74 Million AUD | 59.03% |
| 2017 Q1 | 887.13 Thousand AUD | 1931.45% |
| 2017 Q3 | -12.69 Thousand AUD | -101.43% |
| 2017 Q2 | 887.13 Thousand AUD | 0.0% |
| 2016 FY | 1.09 Million AUD | 285.08% |
| 2016 Q2 | 506.18 Thousand AUD | -0.0% |
| 2016 Q1 | 506.18 Thousand AUD | 317.94% |
| 2016 Q4 | 43.67 Thousand AUD | 0.0% |
| 2016 Q3 | 43.67 Thousand AUD | -91.37% |
| 2015 Q3 | 121.11 Thousand AUD | 458.73% |
| 2015 Q4 | 121.11 Thousand AUD | 0.0% |
| 2015 Q2 | 21.67 Thousand AUD | 0.0% |
| 2015 Q1 | 21.67 Thousand AUD | 0.0% |
| 2015 FY | 285.58 Thousand AUD | 1039.69% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q3 | - AUD | -100.0% |
| 2014 Q2 | 12.52 Thousand AUD | 0.0% |
| 2014 Q1 | 12.52 Thousand AUD | 0.0% |
| 2014 FY | 25.05 Thousand AUD | -26.22% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | 33.96 Thousand AUD | -79.09% |
| 2013 Q3 | - AUD | 0.0% |
| 2012 FY | 162.45 Thousand AUD | -27.13% |
| 2011 FY | 222.93 Thousand AUD | 95.77% |
| 2010 FY | 113.87 Thousand AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2008 FY | 350.56 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |